Navigation Links
More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies
Date:12/3/2008

forward-looking statements contained in this press release as a result of new information, future events or otherwise.

About Novartis Pharmaceuticals Corporation

Novartis Pharmaceuticals Corporation researches, develops, manufactures and markets leading innovative prescription drugs used to treat a number of diseases and conditions, including those in the cardiovascular, metabolic, cancer, organ transplantation, central nervous system, dermatological, GI and respiratory areas. The company's mission is to improve people's lives by pioneering novel healthcare solutions.

Located in East Hanover, New Jersey, Novartis Pharmaceuticals Corporation is an affiliate of Novartis AG which provides healthcare solutions that address the evolving needs of patients and societies. Focused solely on healthcare, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, cost-saving generic pharmaceuticals, preventive vaccines, diagnostic tools, and consumer health products. Novartis is the only company with leading positions in these areas. In 2007, the Group's continuing operations (excluding divestments in 2007) achieved net sales of USD 38.1 billion and net income of USD 6.5 billion. Approximately USD 6.4 billion was invested in R&D activities throughout the Group. Headquartered in Basel, Switzerland, Novartis Group companies employ approximately 97,000 full-time associates and operate in over 140 countries around the world. For more information, please visit http://www.novartis.com.

    Novartis Media Relations

    Media only:           Investors only:
    Geoffrey Cook         Jill Pozarek
    Novartis Oncology     Novartis Corporation
    P: +1 862 778 2675    P: +1 212 830 2445
    F: +1 973 652 7927

    Dana Kahn Cooper
    P: +1 732 817 1800
    F: +1 732 817 1834


'/>"/>
SOURCE Novartis Pharmaceuticals Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

Related medicine technology :

1. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
2. Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting
3. Genta Clinical Programs Featured in Multiple Abstracts at the Annual Meeting of the American Society of Clinical Oncology
4. Biodel Inc. Announces the Completion of Its Two Pivotal Trials and the Release of EASD Abstracts Containing Additional Interim Data From Its VIAject(TM) Program
5. New Data Reveal Topical Divigel(R) (estradiol gel) 0.1% Significantly Reduces Frequency and Severity of Hot Flashes
6. Study Results Reveal alli(R) Patient Satisfaction Linked to Weight Loss Achieved; Not Treatment Effects
7. A Sociolinguistic Analysis of In-Office Dialogue Reveals Psychiatrists and Parents Have Significantly Different Perceptions on ADHD and Psychiatric Comorbidities
8. New Conflict of Interest Violations Revealed at California Stem Cell Institute
9. St. Jude Gene Study Reveals Basis of Anti-Cancer Drug Resistance in Childhood Leukemia
10. Protein Tomography(TM) Reveals Molecular Mode of Action of Humax-EGFr Published in PNAS
11. Imaging Results From the ADAGIO-LIPIDS Reveal That Effects of Rimonabant on Cardiometabolic Risk Profile Include Loss of Visceral Fat and Mobilization of Liver Fat
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... -- Dr. Mark Rasak , MD is recognized by ... in the field of Medicine as a result of ... Dr. Rasak has over 15 years of experience ... business; overseeing the daily operations; interventional cardiology; complex coronary ... he is an honored Fellow of the American Board ...
(Date:8/22/2014)... , Cali ., Aug. 22, 2014 /PRNewswire/ ... Conference shows that a therapy being developed by Hera Therapeutics ... that cause 70 percent of all cervical cancer. ... the replication of HPV-16, HPV-18 and HPV-11 cells, according to ... , Ph.D., who presented the findings at the ...
(Date:8/22/2014)... , Aug. 22, 2014 /PRNewswire/ - SQI ... that develops and commercializes proprietary technologies and products ... has entered into a Master Service Agreement to ... DNA-based pathogen detection assays. During the initial phase ... deliver an automated working prototype of one of ...
Breaking Medicine Technology:Dr. Mark Rasak, MD is recognized by Continental Who's Who with the Diamond Lifetime Achievement Award 2Study shows Hera Therapeutics experimental compound shuts down human papillomavirus that causes most cervical cancer 2SQI Diagnostics Contracted to Automate Pathogen Detection Assays 2SQI Diagnostics Contracted to Automate Pathogen Detection Assays 3
... 16, 2011 The largest human dermal allograft available on ... be introduced at the AWR meeting here this week.  The ... introducing FlexHD acellular hydrated dermal matrix 20 cm ... x 25 cm grafts. FlexHD large ...
... June 16, 2011 Reata Pharmaceuticals , Inc. and ... clinical trial to evaluate the safety and efficacy of bardoxolone methyl ... and type 2 diabetes. The trial, known as BEACON ... with C hronic kidney disease and type 2 diabetes: the ...
Cached Medicine Technology:Largest Acellular Dermal Allografts Available for Abdominal Wall Reconstruction Introduced at AWR 2011 2Reata and Abbott Initiate Global Phase 3 Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes 2Reata and Abbott Initiate Global Phase 3 Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes 3
(Date:8/22/2014)... UK (PRWEB) August 22, 2014 The ... recent past, specifically in the developing world, has led ... and the number of deaths due to AIDS globally. ... declining, the number of new patients becoming affected by ... conscious efforts being undertaken by all related organisations and ...
(Date:8/22/2014)... Ohio (PRWEB) August 22, 2014 Dayton Children's ... care tower as part of a $141 million campus renewal. ... patient care tower were unveiled to the public. , ... facilities plan that will create a campus that meets the ... future. These new care spaces will embody Dayton Children’s unique ...
(Date:8/22/2014)... PA (PRWEB) August 22, 2014 Menstrual ... An inventor from Sunrise, Fla., decided that there needed ... , Easy to use and producible in design variations, ... stains caused by leaks, which avoids embarrassment and promotes ... to conventional sanitary pads. , The original design was ...
(Date:8/22/2014)... 22, 2014 (HealthDay News) -- Many children get anxious ... but there are a number of ways that parents ... expert suggests. The first step is to explain ... help protect their health, said Rita John, director of ... University School of Nursing in New York City. ...
(Date:8/22/2014)... Cleveland, Ohio (PRWEB) August 22, 2014 A ... the mood-food connection. The summit is no-cost and open ... their best kept secrets, practical tips and advice on how ... to lose or manage weight. Mindful eating is not ... decisions and stay motivated instead of an "eat this, don't ...
Breaking Medicine News(10 mins):Health News:Worldwide HIV Infection Drug Market Examined in New Kuick Research Report Published at MarketPublishers.com 2Health News:Worldwide HIV Infection Drug Market Examined in New Kuick Research Report Published at MarketPublishers.com 3Health News:Dayton Children's Hospital Breaks Ground on New, Eight-story Patient Care Tower 2Health News:Dayton Children's Hospital Breaks Ground on New, Eight-story Patient Care Tower 3Health News:Dayton Children's Hospital Breaks Ground on New, Eight-story Patient Care Tower 4Health News:Dayton Children's Hospital Breaks Ground on New, Eight-story Patient Care Tower 5Health News:Simple Steps Make Shots Less Scary for Kids, Nurse Says 2Health News:20 Top Experts Discuss How to Unravel the Food-Mood Connection 2
... Golf can be a good investment for the health, according ... Institutet. The death rate for golfers is 40 per cent ... and socioeconomic status, which correspond to a 5 year increase ... safest. , It is a well-known fact that exercise ...
... 2008) Results from a pivotal Phase III ... oral, once-daily, investigational anticoagulant medication, was superior in ... total knee replacement (TKR) surgery. The head-to-head study ... enoxaparin, the current standard of care. , Data ...
... May 30 Lutronic, Inc., one of,the world,s ... today that its MOSAIC eCO2 system, the next ... the deep,ablative features of a CO2 laser, is ... With intuitive touch-screen software, the powerful MOSAIC ...
... May 30 /PRNewswire-FirstCall/ - Predictive medicine company,PreMD Inc. ... been notified by,the American Stock Exchange (the "AMEX") ... for regaining compliance with the continued listing,standards and ... stock from the,Exchange by filing a delisting application ...
... less likely than white women to receive the radiation ... according to a study that Dana-Farber Cancer Institute researchers ... Society of Clinical Oncology in Chicago. , Although the ... that thousands of black and Hispanic breast cancer patients ...
... COLUMBUS, Ohio Medical researchers at The Ohio State ... a $34 million grant from the National Institutes of ... translational protocols that help identify and advance treatments for ... received by Ohio State. , The Ohio State University ...
Cached Medicine News:Health News:Golf prolongs life 2Health News:Rivaroxaban phase III pivotal data presented at EFORT annual meeting 2Health News:Rivaroxaban phase III pivotal data presented at EFORT annual meeting 3Health News:Soon to Be Released: Lutronic Announces the MOSAIC eCO2, the World's First 'Smart' Fractional CO2 Laser System for Treating Aesthetic and Dermatological Conditions, Will Soon Be Coming to the U.S. Market for Commercial Use 2Health News:Soon to Be Released: Lutronic Announces the MOSAIC eCO2, the World's First 'Smart' Fractional CO2 Laser System for Treating Aesthetic and Dermatological Conditions, Will Soon Be Coming to the U.S. Market for Commercial Use 3Health News:Delisting Notification Received from the American Stock Exchange 2Health News:Blacks, Hispanics less likely than whites to receive follow-up radiation for early breast cancer 2Health News:Ohio State receives $34M NIH grant 2
... developed to create physically secured rooms that ... are converted to RFID portals. These Intelli-Storeroom™ ... antennas by VerdaSee's Field Engineering experts. RFID ... that are to be tracked. The assets ...
... enabled Med Station provides a real time ... during anesthesia. The portable workstation automatically tracks ... removed. The system automatically reorders product from ... tracks expiration dates, catalog numbers and lot ...
... VerdaSee Location-ID™ is a family ... track equipment and individuals inside hospitals, ... radio frequency technology. The target tracking ... through a series of radio frequency ...
Assetrac allows identification, location, and protection of your assets....
Medicine Products: